Navigation Links
Sanofi-aventis Announces Second Quarter 2009 Results
Date:7/29/2009

9.

Also in May, sanofi-aventis announced the construction of a new vaccine production facility in France. This facility will have the capacity to produce 100 million doses of the novel vaccine against dengue fever, currently under development, and is expected to be operational in 2013.

First-half consolidated net sales for the Vaccines business were up 3.7% at euro 1,339 million. Excluding H5N1 sales, net sales rose by 13.7%.

On July 27th, Sanofi Pasteur announced the signature of a strategic agreement for the acquisition of Merieux Alliance's subsidiary ShanH, which owns a majority stake in the Indian vaccine company Shantha Biotechnics.

                                Change at            Change at
                                constant             constant
                        Q2 2009 exchange   H1 2009   exchange
    Millions of euros net sales  rates    net sales   rates
    ----------------- --------- --------  ---------- --------

    Polio/
     Pertussis/
     Hib Vaccines
     (including
     Pentacel(R)
     and
     Pentaxim(R))         259      +28.9%      495        +31.3%
    ---------------   -----     -------     ----     --------
    Influenza
     Vaccines*
     (including
     Vaxigrip(R)
     and
     Fluzone(R))           57      -65.8%**    120       -41.0%**
    ---------------   -----     -------     ----     --------
    Meningitis/
     Pneumonia
     Vaccines
     (including
     Menactra(R))         143       +15.6%     259         +2.7%
    ---------------   -----     -------     ----     --------
    Adult
     Booster
     Vaccines
     (including
     Adacel (R))          106        -4.1%     202         -8.5%
    ---------------   -----     -------     ----     --------
    Travel and
     Other
     Endemic
     Vaccines            88        +9.0%     165         +2.5%
    ---------------   -----     
'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that investors including Oracle ... Fund LLC and several Vermillion directors have agreed ... of Vermillion,s common stock and warrants to purchase ... private placement.  Under the terms ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The ... global leader of technical training across the life sciences ... Data Management (SCDM) to provide the organization's members ... programs —providing access to the more than 350 sessions ... members with 10% off when registering for a ...
(Date:12/22/2014)... Calif. , Dec. 22, 2014  ( www.competitivehealth.com ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... William Heiser, Ph.D., Research ... Hercules, CA 94547, , ... We have found that the most ... distance and,microparticle size. Changing most other parameters, within a,broad range, ...
... A. Kimberley McAllister, Nina Tang, Lawrence C. Katz, and Donald ... Department of Neurobiology, Box 3209, Duke University Medical Center, , ... , Introduction ... cells and tissues of interest , remains a rate-limiting ...
... Katja Kapp, Werner Kunz, and Christoph G Grevelding,Institute for Genetics, Center of ... , Introduction ... parasitic helminths that cause bilharzia (schistosomiasis) , ... al.1997). , One focus of ...
Cached Biology Technology:Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 2Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 3Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 4Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 5Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 6Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 7Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 8Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 9Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 10Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 11Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 12Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 13Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 14Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 15Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 16Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System 17Biolistic Transfection of Organotypic Brain Slices 2Biolistic Transfection of Organotypic Brain Slices 3Biolistic Transfection of Organotypic Brain Slices 4Biolistic Transfection of Organotypic Brain Slices 5Biolistic Transfection of Organotypic Brain Slices 6Biolistic Transfection of Organotypic Brain Slices 7Biolistic Transfection of Organotypic Brain Slices 8Biolistic Transfection of Organotypic Brain Slices 9Biolistic Transfection of Organotypic Brain Slices 10Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 2Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 3Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 4Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 5Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 6Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 7Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 8Biolistic Gene Transfer to Generate Transgenic Schistosomes, Rev A 9
(Date:12/10/2014)... -- You,ve been here before: you desperately need to sign ... site key or the answer to your secret question. What,s ... Today, Hoyos Labs , a digital infrastructure ... put an end to the frustration that comes with usernames, ... leverages a user,s smartphone to acquire his or her biometrics ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
(Date:12/4/2014)... Fla. , Dec. 3, 2014  Crossmatch™, ... today announced that its DigitalPersona ® Pro ... readers have been deployed throughout First Bank branch ... South Carolina and Virginia. First ... Southern Pines, North Carolina , ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... launched a collaborative project to develop and evaluate new ... AvecNet is a five year, 12 million project ... the European Union,s Seventh Framework programme. Because malaria ... to combating the disease. Wide scale use of ...
... and the United Kingdom have been awarded funding ... process of biological photosynthesis. The U.S. National Science ... Sciences Research Council (BBSRC) collaborated in issuing these ... to use sunlight and carbon dioxide to produce ...
... a resident in Medical Genetics in the Department of ... Medical Center, in Stanford Calif., was honored as the ... Foundation Clinical Genetics Fellowship in Biochemical Genetics at the ... Canada. The objective of the Genzyme/ACMG Foundation Award ...
Cached Biology News:€12 million ($16.9 million) project to develop new tools for malaria control 2NSF announces new awards that will investigate more efficient ways to harvest sunlight 2NSF announces new awards that will investigate more efficient ways to harvest sunlight 3NSF announces new awards that will investigate more efficient ways to harvest sunlight 4
KAI 1 (G-2)...
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...
Anti-OSMR Monoclonal Antibody Research Focus: cytokine/growth factor Storage: 4C Shipping Temperature: 4C...
... Yeast Cells are designed for use with ... cerevisiae strain MaV203 contains deletions in the ... with GAL4-based two-hybrid systems. The strain also ... of ProQuest bait and prey vectors. MaV203 ...
Biology Products: